Cost-effectiveness of Lee Silverman Voice Treatment LOUD (LSVT®) versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease: An economic evaluation alongside the PD COMM trial
Objective: We evaluated the cost effectiveness of two speech and language therapy techniques compared with no therapy in people with Parkinson's disease who have problems…Is there a common structural network for stimulation-induced dysarthria in subthalamic and thalamic deep brain stimulation?
Objective: To identify a common structural network for stimulation-induced dysarthria (SID) in thalamic deep brain stimulation (DBS) and DBS of the Nucleus subthalamicus (STN). Background:…Apathy and impulsivity co-occur in Huntington’s disease
Objective: To determine whether apathy and impulsivity co-occur in people with Huntington’s disease. Background: Apathy and impulsivity are debilitating behavioural changes which often occur in…Spiral drawing features are similar between essential tremor and essential tremor plus
Objective: To explore the features on free hand spirals drawn by patients with essential tremor and essential tremor plus. Background: The 2018 consensus statement on…Towards smart glasses for improved care of individuals with Parkinson’s disease
Objective: To evaluate the applicability of sensor-enabled smart glasses for remote tracking of symptoms related to Parkinson’s disease Background: Diagnosis and monitoring of PD by…Neuroimaging analysis of postural instability in Progressive Supranuclear Palsy: a Voxel‐based morphometry approach
Objective: The aim of the study was to identify the mainly brain regions involved in postural instability (PI) in Progressive Supranuclear Palsy (PSP) with a…Initial clinical experience with levodopa-entacapone-carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson´s disease in Croatia
Objective: To report preliminary results of a 12-week, prospective, multicenter, observational study of the efficacy and safety of LECIG for the treatment of advanced Parkinson´s…Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine
Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…Inferring Rigidity Scores in MDS-UPDRS Motor Assessment from Other Items
Objective: This study aimed to explore the possibility of inferring rigidity scores in MDS-UPDRS assessments from other items to enhance the accuracy of clinical evaluations…The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated intestinal dysfunction in Parkinson’s Disease
Objective: The aim of this study is to explore the function and mechanism of RNA m6A modification in gut-derived inflammation of Parkinson's disease (PD). Background:…
- « Previous Page
- 1
- …
- 362
- 363
- 364
- 365
- 366
- …
- 1554
- Next Page »